Shah Sujal
SEC insider (Form 3/4/5 filer). CIK 0001588861. Director at Tvardi Therapeutics, Inc. (TVRD). 4 reported Form 4/5 transactions since Sep 2024; latest on Jun 9, 2026. Located in SUGAR LAND, TX.
Companies Shah Sujal has filed insider reports for
- Tvardi Therapeutics, Inc. (TVRD): Director
Shah Sujal
CIK: 0001588861
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Tvardi Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 9, 2026TVRD
Tvardi Therapeutics, Inc.
AwardDirectStock Option (right to buy)
6K shares- - Apr 17, 2025TVRD
Tvardi Therapeutics, Inc.
AwardDirectStock Option (right to buy)
12K shares- - Apr 15, 2025TVRD
Tvardi Therapeutics, Inc.
AwardDirectStock Option (right to buy)
10.4K shares- - Apr 15, 2025TVRD
Tvardi Therapeutics, Inc.
AwardDirectStock Option (right to buy)
8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 9, 2026 | TVRD Tvardi Therapeutics, Inc. | Award Stock Option (right to buy) | 6,000 | - | - | Direct |
| Apr 17, 2025 | TVRD Tvardi Therapeutics, Inc. | Award Stock Option (right to buy) | 12,000 | - | - | Direct |
| Apr 15, 2025 | TVRD Tvardi Therapeutics, Inc. | Award Stock Option (right to buy) | 10,394 | - | - | Direct |
| Apr 15, 2025 | TVRD Tvardi Therapeutics, Inc. | Award Stock Option (right to buy) | 8,047 | - | - | Direct |
1-4 of 4 transactions